Article
Tumor-specific prognosis of mutation-positive patients with head and neck paragangliomas.
Journal of vascular surgery - 1 May 2020
Sen Indrani, Young William F, Kasperbauer Jan L, Polonis Katarzyna, Harmsen William S, Colglazier Jill J, DeMartino Randall R, Oderich Gustavo S, Kalra Manju, Bower Thomas C
Abstract excerpt
BACKGROUND: Genetic testing to identify succinate dehydrogenase (SDH) mutations in patients with head and neck paraganglioma (HNP) has been in clinical practice for more than a decade. However, the recurrence and metachronous tumor occurrence risks in surgically treated mutation-positive patients are not well studied. METHODS: Clinical and procedural details of consecutive patients who underwent excision for HNP...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
